PCBL Chemical Limited — Investor Meet, 07-05-2026: Analysts/Institutional Investor Meet/Con. Call Updates

PCBL Chemical navigated Q4 FY26 with margin pressure from West Asia conflict-driven cost hikes. Recovery signals are noted: stabilized spreads, US tariff benefits, and India-EU FTA. Carbon black capacity reached 880,000 TPA, with new specialty lines commissioning soon. Nanovace's battery chemicals pilot plant is also ready for validation. Management projects double-digit EBITDA growth for FY27, driven by volume, significant cost savings (INR 200-250 Cr expected), and better pricing. Net borrowings reduced by INR 454 Cr. Aquapharm targets 20-25% top-line growth and INR 75 Cr quarterly EBITDA run rate, fueled by higher utilization and new product approvals. Outlook is confident on future profitability and debt reduction.